Brand name authorized in: Austria
The drug ADRIBLASTIN contains one active pharmaceutical ingredient (API):
Doxorubicin is a cytotoxic anthracycline antibiotic obtained from Streptomyces peucetius var. caesius. The exact mechanism of the antitumour activity of doxorubicin is not known. It is generally believed that inhibition of DNA, RNA and protein synthesis is responsible for the majority of the cytotoxic effects.
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows: